{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Other\" and posted_year = 2001 sorted by posted_date descending", "rows": [["FDA-2001-P-0155-0001", "FDA", "FDA-2001-P-0155", "FDA/DDM to Arnall, Golden Gregory", "Other", "ACK-Acknowledgement Letter", "2001-12-27T05:00:00Z", 2001, 12, null, null, "2008-04-25T02:27:48Z", null, 0, 0, "09000064804df043"], ["FDA-2001-P-0053-0001", "FDA", "FDA-2001-P-0053", "Acknowledgment Letter from FDA DMB to Wilmer, Cutler & Pickering", "Other", "Acknowledgement Letter/Receipt", "2001-12-27T05:00:00Z", 2001, 12, null, null, "2024-09-23T22:37:14Z", null, 0, 0, "09000064804b7e38"], ["FDA-2001-P-0452-0001", "FDA", "FDA-2001-P-0452", "Approval Letter from FDA CDER to AA1 International", "Other", "Approval", "2001-12-17T05:00:00Z", 2001, 12, "2021-01-28T05:00:00Z", null, "2021-02-01T17:19:08Z", null, 0, 0, "0900006484a0af87"], ["FDA-2001-P-0191-0001", "FDA", "FDA-2001-P-0191", "FDA/DDM to Hogan &amp; Hartson, LLP", "Other", "ACK-Acknowledgement Letter", "2001-12-11T05:00:00Z", 2001, 12, null, null, "2008-04-25T02:25:58Z", null, 0, 0, "09000064804e2665"], ["FDA-2001-P-0215-0002", "FDA", "FDA-2001-P-0215", "Acknowledgment Letter from FDA DMB to Omega Laboratories, Ltd.", "Other", "ACK-Acknowledgement Letter", "2001-12-07T05:00:00Z", 2001, 12, null, null, "2024-08-23T13:49:30Z", null, 0, 0, "09000064804e488d"], ["FDA-2001-P-0086-0002", "FDA", "FDA-2001-P-0086", "FDA/OC  to Washington Legal Foundation", "Other", "LET-Letter", "2001-11-27T05:00:00Z", 2001, 11, null, null, "2008-04-25T02:23:19Z", null, 0, 0, "09000064804b8543"], ["FDA-1978-N-0018-0440", "FDA", "FDA-1978-N-0018", "Memorandum of Meeting Between FDA/OCC and Cosmetic, Toiletry and Fragrance Association", "Other", "Memorandum", "2001-11-19T05:00:00Z", 2001, 11, null, null, "2019-08-07T12:11:46Z", null, 0, 0, "090000648055a7fe"], ["FDA-1980-N-0074-0075", "FDA", "FDA-1980-N-0074", "FDA/ORA to Colgate-Palmolive Company", "Other", "PDN-Petition Denial", "2001-11-14T05:00:00Z", 2001, 11, null, null, "2008-05-30T22:52:47Z", null, 0, 0, "09000064805bb4db"], ["FDA-2018-D-4115-0013", "FDA", "FDA-2018-D-4115", "The Mammography Quality Standards Act Final Regulations: Preparing For MQSA Inspections; Final Guidance for Industry and FDA", "Other", "Guidance", "2001-11-04T05:00:00Z", 2001, 11, "2001-11-04T05:00:00Z", null, "2024-11-06T23:36:50Z", null, 1, 0, "0900006484644a3f"], ["FDA-2001-P-0239-0005", "FDA", "FDA-2001-P-0239", "Letter from FDA CFSAN to Krislov & Associates, LTD.", "Other", "Letter(s)", "2001-10-31T05:00:00Z", 2001, 10, "2020-07-06T04:00:00Z", null, "2024-09-09T17:22:16Z", null, 0, 0, "09000064804e6814"], ["FDA-2001-P-0239-0004", "FDA", "FDA-2001-P-0239", "Letter from FDA CFSAN to Center for Food Safety", "Other", "Letter(s)", "2001-10-31T05:00:00Z", 2001, 10, "2020-07-06T04:00:00Z", null, "2024-09-09T17:22:06Z", null, 0, 0, "09000064804e6812"], ["FDA-1999-P-0059-0004", "FDA", "FDA-1999-P-0059", "FDA/DMB to Health Care Without Harm", "Other", "ACK-Acknowledgement Letter", "2001-10-05T04:00:00Z", 2001, 10, null, null, "2008-04-25T00:13:56Z", null, 0, 0, "09000064804a671c"], ["FDA-1996-P-0041-0001", "FDA", "FDA-1996-P-0041", "Memorandum from FDA, Dave Read (HFD-7) to FDA Dockets Management Branch (HFA-305)", "Other", "Memorandum", "2001-09-19T04:00:00Z", 2001, 9, null, null, "2024-06-20T14:22:26Z", null, 0, 0, "09000064804fc5e9"], ["FDA-2001-E-0027-0001", "FDA", "FDA-2001-E-0027", "FDA/CDER to the U. S. Patent & Trademark Office - Letter", "Other", "LET-Letter", "2001-09-12T04:00:00Z", 2001, 9, null, null, "2010-01-29T15:43:16Z", null, 0, 0, "09000064804b5c4f"], ["FDA-2001-P-0216-0002", "FDA", "FDA-2001-P-0216", "FDA/CDER to Paul, Hastings, Janofsky &amp; Walker LLP", "Other", "LET-Letter", "2001-09-11T04:00:00Z", 2001, 9, null, null, "2008-04-25T02:38:56Z", null, 0, 0, "09000064804e4a25"], ["FDA-1999-P-0059-0003", "FDA", "FDA-1999-P-0059", "FDA/CDRH to Sanford J. Lewis", "Other", "PDN-Petition Denial", "2001-09-11T04:00:00Z", 2001, 9, null, null, "2008-04-25T00:13:56Z", null, 0, 0, "09000064804a671a"], ["FDA-2001-P-0001-0002", "FDA", "FDA-2001-P-0001", "FDA/CDER to Mutual Pharmaceutical Company", "Other", "LET-Letter", "2001-09-11T04:00:00Z", 2001, 9, null, null, "2008-04-25T02:25:38Z", null, 0, 0, "09000064804b3acf"], ["FDA-2001-P-0056-0003", "FDA", "FDA-2001-P-0056", "FDA/CDER to Pharmaceutical Associates Inc", "Other", "PAV-Petition Approval", "2001-08-27T04:00:00Z", 2001, 8, null, null, "2008-04-25T01:57:35Z", null, 0, 0, "09000064804b7ec8"], ["FDA-2001-P-0239-0003", "FDA", "FDA-2001-P-0239", "Amendment from Krislov & Associates, LTD.", "Other", "Amendment", "2001-08-23T04:00:00Z", 2001, 8, "2020-07-06T04:00:00Z", null, "2020-07-06T22:32:12Z", null, 0, 0, "09000064804e680f"], ["FDA-1999-N-0113-0168", "FDA", "FDA-1999-N-0113", "Draft Agenda for March 20, 2001 meeting", "Other", "LST-List", "2001-08-03T04:00:00Z", 2001, 8, null, null, "2008-04-25T00:17:47Z", null, 0, 0, "09000064804ae795"], ["FDA-1999-N-0134-0009", "FDA", "FDA-1999-N-0134", "HHS/USDA Action Plan", "Other", "TS-Testimony", "2001-08-03T04:00:00Z", 2001, 8, null, null, "2008-04-25T00:16:59Z", null, 0, 0, "09000064804aebb5"], ["FDA-1999-N-0113-0169", "FDA", "FDA-1999-N-0113", "Summary of the Draft Risk Assessment", "Other", "TS-Testimony", "2001-08-03T04:00:00Z", 2001, 8, null, null, "2008-04-25T00:17:45Z", null, 0, 0, "09000064804ae798"], ["FDA-1999-N-0134-0007", "FDA", "FDA-1999-N-0134", "Listeriosis in the United States", "Other", "TS-Testimony", "2001-08-03T04:00:00Z", 2001, 8, null, null, "2008-04-25T00:17:00Z", null, 0, 0, "09000064804aebb3"], ["FDA-1999-N-0134-0006", "FDA", "FDA-1999-N-0134", "Agenda for March 19, 2001 Public Meeting", "Other", "LST-List", "2001-08-03T04:00:00Z", 2001, 8, null, null, "2008-04-25T00:17:00Z", null, 0, 0, "09000064804aebb2"], ["FDA-1999-N-0134-0008", "FDA", "FDA-1999-N-0134", "Draft Assessment of the Relative Risk", "Other", "TS-Testimony", "2001-08-03T04:00:00Z", 2001, 8, null, null, "2008-04-25T00:16:58Z", null, 0, 0, "09000064804aebb4"], ["FDA-1999-N-0113-0170", "FDA", "FDA-1999-N-0113", "Risk Reduction Strategy for Vibrio parahaemolyticus", "Other", "TS-Testimony", "2001-08-03T04:00:00Z", 2001, 8, null, null, "2008-04-25T00:17:41Z", null, 0, 0, "09000064804ae79b"], ["FDA-2001-P-0190-0001", "FDA", "FDA-2001-P-0190", "FDA/DDM to Washington Legal Foundation", "Other", "ACK-Acknowledgement Letter", "2001-08-01T04:00:00Z", 2001, 8, null, null, "2008-04-25T02:27:37Z", null, 0, 0, "09000064804e2531"], ["FDA-2001-P-0156-0002", "FDA", "FDA-2001-P-0156", "FDA/CDER to Tom Stothoff", "Other", "LET-Letter", "2001-07-27T04:00:00Z", 2001, 7, null, null, "2008-04-25T02:25:53Z", null, 0, 0, "09000064804df2a0"], ["FDA-2001-P-0152-0001", "FDA", "FDA-2001-P-0152", "FDA/DDM", "Other", "ACK-Acknowledgement Letter", "2001-07-25T04:00:00Z", 2001, 7, null, null, "2008-04-25T02:27:08Z", null, 0, 0, "09000064804ddd42"], ["FDA-2001-P-0126-0001", "FDA", "FDA-2001-P-0126", "FDA/DDM to TestoCreme, LLC", "Other", "ACK-Acknowledgement Letter", "2001-07-13T04:00:00Z", 2001, 7, null, null, "2008-04-25T02:27:41Z", null, 0, 0, "09000064804dd948"], ["FDA-2000-P-0151-0002", "FDA", "FDA-2000-P-0151", "FDA/CFSAN to Sartori Food Corp.", "Other", "LET-Letter", "2001-07-11T04:00:00Z", 2001, 7, null, null, "2008-04-25T01:31:51Z", null, 0, 0, "09000064804d117f"], ["FDA-1980-N-0074-0073", "FDA", "FDA-1980-N-0074", "FDA/ORA to Hyman, Phelps &amp; McNamara, P. C.", "Other", "PDN-Petition Denial", "2001-07-09T04:00:00Z", 2001, 7, null, null, "2008-05-30T22:53:22Z", null, 0, 0, "09000064805bb4d8"], ["FDA-2001-P-0125-0001", "FDA", "FDA-2001-P-0125", "FDA/DMB to Ferndale Laboratories Inc.", "Other", "ACK-Acknowledgement Letter", "2001-07-02T04:00:00Z", 2001, 7, null, null, "2008-04-25T02:26:16Z", null, 0, 0, "09000064804dd914"], ["FDA-2001-P-0055-0001", "FDA", "FDA-2001-P-0055", "FDA/DDM to Ferndale Laboratories, Inc.", "Other", "ACK-Acknowledgement Letter", "2001-07-02T04:00:00Z", 2001, 7, null, null, "2008-04-25T01:57:35Z", null, 0, 0, "09000064804b7e8a"], ["FDA-2020-D-1954-0001", "FDA", "FDA-2020-D-1954", "Small Entity Compliance Guide: Safe Handling Statements on Labeling of Shell Eggs and the Refrigeration of Shell Eggs Held for Retail Distribution", "Other", "Guidance", "2001-07-01T04:00:00Z", 2001, 7, "2020-09-21T04:00:00Z", null, "2024-11-12T23:24:58Z", null, 1, 0, "090000648486938a"], ["FDA-2000-D-0278-0001", "FDA", "FDA-2000-D-0278", "Guidance for Industry: Refusal of Inspection or Access to HACCP Records Pertaining to the Safe and Sanitary Processing of Fish and Fishery Products", "Other", "Guidance", "2001-07-01T04:00:00Z", 2001, 7, "2020-09-29T04:00:00Z", null, "2024-11-06T23:39:12Z", null, 1, 0, "090000648489ae28"], ["FDA-2020-D-1955-0001", "FDA", "FDA-2020-D-1955", "Small Entity Compliance Guide: Serving Sizes Reference Amount for Baking Powder, Baking Soda, and Pectin", "Other", "Guidance", "2001-07-01T04:00:00Z", 2001, 7, "2020-09-21T04:00:00Z", null, "2024-11-06T23:39:28Z", null, 1, 0, "090000648486938c"], ["FDA-1980-N-0074-0072", "FDA", "FDA-1980-N-0074", "HFD-560 to Warner Lambert Consumer Healthcare", "Other", "LET-Letter", "2001-06-28T04:00:00Z", 2001, 6, null, null, "2008-05-30T22:53:09Z", null, 0, 0, "09000064805bb4d7"], ["FDA-2001-P-0088-0001", "FDA", "FDA-2001-P-0088", "FDA/DDM to the Weinberg Group Inc.", "Other", "ACK-Acknowledgement Letter", "2001-06-26T04:00:00Z", 2001, 6, null, null, "2008-04-25T02:24:43Z", null, 0, 0, "09000064804b8615"], ["FDA-2001-P-0124-0001", "FDA", "FDA-2001-P-0124", "FDA/DDM to GlaxoSmithKline", "Other", "ACK-Acknowledgement Letter", "2001-06-14T04:00:00Z", 2001, 6, null, null, "2008-04-25T02:25:49Z", null, 0, 0, "09000064804dd8dc"], ["FDA-2001-P-0193-0001", "FDA", "FDA-2001-P-0193", "FDA/DDM to Mallinckrodt, Inc.", "Other", "ACK-Acknowledgement Letter", "2001-05-30T04:00:00Z", 2001, 5, null, null, "2008-04-25T02:27:23Z", null, 0, 0, "09000064804e2a9e"], ["FDA-2001-P-0086-0001", "FDA", "FDA-2001-P-0086", "FDA/DDM to Washington Legal Foundation", "Other", "ACK-Acknowledgement Letter", "2001-05-30T04:00:00Z", 2001, 5, null, null, "2008-04-25T02:23:19Z", null, 0, 0, "09000064804b8533"], ["FDA-2001-P-0090-0001", "FDA", "FDA-2001-P-0090", "FDA/DDM to Devices &amp; Diagnostics Consulting Group, Inc.", "Other", "ACK-Acknowledgement Letter", "2001-05-17T04:00:00Z", 2001, 5, null, null, "2008-04-25T02:24:05Z", null, 0, 0, "09000064804b89a6"], ["FDA-1998-P-0046-0002", "FDA", "FDA-1998-P-0046", "FDA/CDRH to Levin Fishbein Sedran &amp; Berman", "Other", "PDN-Petition Denial", "2001-05-16T04:00:00Z", 2001, 5, null, null, "2008-05-16T21:47:38Z", null, 0, 0, "090000648056e6f7"], ["FDA-1998-P-0018-0004", "FDA", "FDA-1998-P-0018", "Citizen Petition Denial from FDA CDER to King & Spalding", "Other", "Denial of Petition", "2001-05-10T04:00:00Z", 2001, 5, null, null, "2024-07-12T16:59:04Z", null, 0, 0, "0900006480563c55"], ["FDA-2000-P-0024-0003", "FDA", "FDA-2000-P-0024", "FDA/CDER to Pharmaceutical Associates Inc", "Other", "PDN-Petition Denial", "2001-05-10T04:00:00Z", 2001, 5, null, null, "2008-04-25T01:13:49Z", null, 0, 0, "09000064804aea00"], ["FDA-2000-P-0212-0002", "FDA", "FDA-2000-P-0212", "FDA/CDER to New Jersey General Assembly", "Other", "LET-Letter", "2001-05-08T04:00:00Z", 2001, 5, null, null, "2008-04-25T01:47:09Z", null, 0, 0, "09000064804d4d8f"], ["FDA-2001-P-0030-0001", "FDA", "FDA-2001-P-0030", "Acknowledgement Letter to Duramed Pharmaceuticals Inc.", "Other", "ACK-Acknowledgement Letter", "2001-05-02T04:00:00Z", 2001, 5, null, null, "2010-03-11T23:01:24Z", null, 0, 0, "09000064804b602e"], ["FDA-2001-P-0056-0002", "FDA", "FDA-2001-P-0056", "FDA/DDM to Pharmaceutical Associates, Inc.", "Other", "ACK-Acknowledgement Letter", "2001-04-25T04:00:00Z", 2001, 4, null, null, "2008-04-25T01:57:35Z", null, 0, 0, "09000064804b7ec7"], ["FDA-2001-P-0239-0001", "FDA", "FDA-2001-P-0239", "Citizen Petition from Krislov & Associates, LTD.", "Other", "Citizen Petition", "2001-04-23T04:00:00Z", 2001, 4, "2020-07-06T04:00:00Z", null, "2024-07-29T20:36:46Z", null, 0, 0, "09000064804e67f9"], ["FDA-2001-P-0239-0002", "FDA", "FDA-2001-P-0239", "Acknowledgment Letter from FDA DMB to Krislov & Associates, LTD.", "Other", "Acknowledgement Letter/Receipt", "2001-04-23T04:00:00Z", 2001, 4, "2020-07-06T04:00:00Z", null, "2024-09-09T17:21:36Z", null, 0, 0, "09000064804e680d"], ["FDA-2000-D-0067-0002", "FDA", "FDA-2000-D-0067", "Guidance on Medical Device Patient Labeling:  Final Guidance for Industry and FDA Staff", "Other", "Guidance", "2001-04-19T04:00:00Z", 2001, 4, "2001-04-19T04:00:00Z", null, "2024-11-11T21:01:40Z", null, 1, 0, "0900006481b68183"], ["FDA-1999-D-0188-0002", "FDA", "FDA-1999-D-0188", "Guidance for Industry Effect of Anthelmintics : Specific Recommendations for Ovine  VICH GL13 -  Final Guidance 96", "Other", "Guidance", "2001-04-11T04:00:00Z", 2001, 4, "2001-03-26T05:00:00Z", null, "2020-04-30T19:51:36Z", null, 0, 0, "09000064804b04a6"], ["FDA-1999-D-0188-0001", "FDA", "FDA-1999-D-0188", "Guidance for Industry  Effectiveness of Anthelmintics: Specific Recommendations for Bovine VICH GL12 - Final Guidance 95", "Other", "Guidance", "2001-04-11T04:00:00Z", 2001, 4, "2001-03-26T05:00:00Z", null, "2020-04-30T19:50:46Z", null, 0, 0, "09000064804b04a5"], ["FDA-1999-D-0188-0003", "FDA", "FDA-1999-D-0188", "Guidance for Industry  Effect of Anthelmintics : Specific Recommendations for Caprine VICH GL14 -  Final Guidance 97", "Other", "Guidance", "2001-04-11T04:00:00Z", 2001, 4, "2001-03-26T05:00:00Z", null, "2020-04-30T19:52:20Z", null, 0, 0, "09000064804b04a8"], ["FDA-2000-P-0096-0003", "FDA", "FDA-2000-P-0096", "FDA/CDER to Arnold &amp; Porter", "Other", "LET-Letter", "2001-04-09T04:00:00Z", 2001, 4, null, null, "2008-04-25T01:01:16Z", null, 0, 0, "09000064804b822d"], ["FDA-2001-P-0214-0001", "FDA", "FDA-2001-P-0214", "FDA/DDM to Veigh Hogan Jr.", "Other", "ACK-Acknowledgement Letter", "2001-04-03T04:00:00Z", 2001, 4, null, null, "2008-04-25T02:37:12Z", null, 0, 0, "09000064804e4703"], ["FDA-2001-P-0189-0001", "FDA", "FDA-2001-P-0189", "FDA/CDER to Abbott Laboratories", "Other", "ACK-Acknowledgement Letter", "2001-03-21T05:00:00Z", 2001, 3, null, null, "2008-04-25T02:27:15Z", null, 0, 0, "09000064804e23fa"], ["FDA-2001-P-0056-0001", "FDA", "FDA-2001-P-0056", "FDA/DDM to Pharmaceutical Associates, Inc.", "Other", "ACK-Acknowledgement Letter", "2001-03-16T05:00:00Z", 2001, 3, null, null, "2008-04-25T01:57:35Z", null, 0, 0, "09000064804b7ebe"], ["FDA-2001-D-0506-0002", "FDA", "FDA-2001-D-0506", "Draft Guidance for Industry on Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines; Guidance Document", "Other", "Guidance", "2001-03-09T05:00:00Z", 2001, 3, null, null, "2024-11-07T21:53:22Z", null, 1, 0, "09000064804ef97f"], ["FDA-2001-P-0216-0001", "FDA", "FDA-2001-P-0216", "FDA/DDM to Paul, Hastings, Janofsky &amp; Walker LLP", "Other", "ACK-Acknowledgement Letter", "2001-03-08T05:00:00Z", 2001, 3, null, null, "2008-04-25T02:38:56Z", null, 0, 0, "09000064804e4970"], ["FDA-2001-P-0194-0001", "FDA", "FDA-2001-P-0194", "FDA/DDM to Dade Behring Inc.", "Other", "ACK-Acknowledgement Letter", "2001-03-06T05:00:00Z", 2001, 3, null, null, "2008-04-25T02:38:06Z", null, 0, 0, "09000064804e2bef"], ["FDA-2001-P-0001-0001", "FDA", "FDA-2001-P-0001", "FDA/DDM to Mutual Pharmaceutical Company. Inc.", "Other", "ACK-Acknowledgement Letter", "2001-03-06T05:00:00Z", 2001, 3, null, null, "2008-04-25T02:25:38Z", null, 0, 0, "09000064804b3a7a"], ["FDA-2001-P-0156-0001", "FDA", "FDA-2001-P-0156", "FDA/DDM to Tom Stothoff", "Other", "ACK-Acknowledgement Letter", "2001-02-02T05:00:00Z", 2001, 2, null, null, "2008-04-25T02:25:53Z", null, 0, 0, "09000064804df23f"], ["FDA-2000-D-0598-0005", "FDA", "FDA-2000-D-0598", "FDA GeneTox Network to Dockets Management - Memorandum", "Other", "Memorandum", "2001-01-23T05:00:00Z", 2001, 1, "2013-01-23T05:00:00Z", null, "2013-01-23T19:10:07Z", null, 0, 0, "09000064804dd8b3"]], "truncated": false, "filtered_table_rows_count": 65, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Other", "p2": "2001"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001", "results": [{"value": "FDA", "label": "FDA", "count": 65, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Other&posted_year=2001", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001", "results": [{"value": "Other", "label": "Other", "count": 65, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001", "results": [{"value": 2001, "label": 2001, "count": 65, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Other&posted_year=2001&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 822.9869669303298, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}